Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure

Chest

Volumn 119, Issue 4, 2001, Pages 1173-1178

  Nanas, John N ^a   Kontoyannis, Dimitrios A ^a   Alexopoulos, George P ^a   Anastasiou Nana, Maria I ^a   Tsagalou, Eleftheria P ^a   Stamatelopoulos, Stamatis F ^a   Moulopoulos, Spyridon D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Amiodarone; Congestive heart failure; Dobutamine; Survival

Indexed keywords

AMIODARONE; CREATININE; DOBUTAMINE; SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INTERMITTENT THERAPY; FOLLOW UP; HEALTH STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC MONITORING; HUMAN; LONG TERM CARE; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SURVIVAL; TREATMENT OUTCOME;

EID: 0034925809     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.4.1173     Document Type: Article

References (42)

1. Prevalence and mortality rate of congestive heart failure in the United States
2. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
4. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
5. Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity
6. Clinical classification of cardiac deaths
7. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation
8. Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy
9. The CASCADE Study: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle
10. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone
11. Amiodarone: Historical development and pharmacologic profile
12. Randomised trial of low-dose amiodarone in severe congestive heart failure
13. Xamoterol in severe heart failure
14. Effect of oral milrinone on mortality in severe chronic heart failure
15. Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial: The Western Enoximone Study Group
16. Effects of vesnarinone on morbidity and mortality in patients with heart failure
17. The effect of digoxin on mortality and morbidity in patients with heart failure
18. Home intravenous dobutamine therapy in patients awaiting heart transplantation
19. Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure
20. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients
21. Outpatient dobutamine for refractory congestive heart failure: Advantages, techniques, and results
22. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure
23. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure
24. Intermittent ambulatory dobutamine infusions for patients awaiting cardiac transplantation
25. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure
26. Arrhythmias associated with intermittent outpatient dobutamine infusion
27. Long-term benefit of dobutamine in patients with congestive cardiomyopathy
28. Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine
29. Tolerance to dobutamine after a 72 hour continuous infusion
30. Biphasic adrenergic modulation of β-adrenergic receptors in man: Agonist-induced early increment and late decrement of β-adrenergic receptor number
31. Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure
32. Direct effect of dobutamine on action potential duration in ischemic compared with normal areas in the human ventricle
33. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: A comparative study with dobutamine
34. Comparative effects of prenalterol and dobutamine in a canine model of acute ischemic heart failure
35. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia
36. Drug-induced conditioning in congestive heart failure
37. Conditioning effects of chronic infusions of dobutamine: Comparison with exercise training
38. Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure
39. The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
40. Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure
41. Combined oral positive inotropic and β-blocker therapy for treatment of refractory class IV heart failure
42. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)